Prognostic And Predictive Value Of Esr1 Mutations In Postmenopausal Metastatic Breast Cancer (Mbc) Patients (Pts) Resistant To Aromatase Inhibitors (Ai), Treated With Palbociclib (Pal) In Combination With Endocrine Therapy (Et) Or Capecitabine (Cap) In The Pearl Study.
JOURNAL OF CLINICAL ONCOLOGY（2020）
摘要
1022Background: Prior retrospective data has shown ESR1 mutation is an acquired resistant mechanism to AI. However, little is known about ist prognostic and predictive value to endocrine-based ther...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要